Lv6
2450 积分 2024-08-15 加入
A first-in-human (FiH) phase I study of GFS202A, a GDF15/IL-6 bispecific antibody, in advanced cancer patients (pts) with pre-cachexia or cachexia
1个月前
已完结
A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers
1个月前
已关闭
A Phase 1 Study To Investigate the Safety, Tolerability, and Pharmacokinetics of HSK21542 in Healthy Volunteers
2个月前
已关闭
Serum fasting GLP-1 and GLP-2 associate with intestinal adaptation in pediatric onset intestinal failure
2个月前
已完结
Dual activation of MC3R and MC4R drives weight loss and reduces food intake in male primates with obesity
3个月前
已完结
Additive effect of ALXN2420, a GH receptor antagonist, and octreotide on IGF1 suppression in vivo
4个月前
已完结
Creation of a Peptide Antagonist of the GFRALRET Receptor Complex for the Treatment of GDF15-Induced Malaise
5个月前
已完结
A high-throughput selection system for fast-acting covalent protein drugs
5个月前
已完结
Tumor-immune-neural circuit disrupts energy homeostasis in cancer cachexia
7个月前
已完结
Current and potential therapeutic targets of glucagon-like peptide-2
7个月前
已完结
皖公网安备34019202002308
